Nicola Fusco, Full Professor of Pathology at University of Milan, Director of the Division of Pathology at IEO European Institute of Oncology, shared on LinkedIn:
“Behind the cameras at the IEO Istituto Europeo di Oncologia.
An inspiring conversation with Prof. Giuseppe Curigliano on where precision medicine is heading in metastatic breast cancer.
Something important is coming soon. A global initiative designed to help define a more harmonized approach to patient care, starting from an outstanding molecular testing strategy.
A special thank you to the amazing IEO Communication team – Greta Mostarda and Emanuela Ottolina – for making the shooting day run seamlessly, and to my new assistant Katiuscia Faranda for her invaluable support.”
You can also read ‘CDK2 Inhibition in CDK4/6 – Resistant Breast Cancer: A New Escape Route Under Study‘
